Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
43
Number of overlapping holdings
41.0%
% of BMED's 115 holdings also in XBI
36.4%
% of XBI's 119 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 2.5% | 2.5% |
|
ABBVIE INC | 3.1% | 2.3% | 2.3% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 2.6% | 1.5% |
|
NATERA INC | 1.5% | 2.8% | 1.5% |
|
EXACT SCIENCES CORP | 1.4% | 2.5% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to XBI
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
 |
ARGENX SE ADR | 3.3% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
REPLIGEN CORP | 2.1% |
BMED Underweight Relative to XBI
|
VERTEX PHARMACEUTICALS INC | -2.5% |
|
INCYTE CORP | -2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.3% |
|
REGENERON PHARMACEUTICALS | -2.3% |
|
INSMED INC | -2.0% |
|
BIOMARIN PHARMACEUTICAL INC | -2.0% |
|
MODERNA, INC. | -2.0% |
|
UNITED THERAPEUTICS CORP | -1.8% |
|
TG THERAPEUTICS INC | -1.8% |
|
ALNYLAM PHARMACEUTICALS INC | -1.7% |